PREPARATION OF C1-ESTERASE INHIBITOR (C1-INH), KIT THAT CONSISTS OF A FIRST RECEPTACLE CONTAINING THE PREPARATION OF C1-INH, KIT THAT CONSISTS OF A PRE-FILLED SYRINGE WITH THE PREPARATION OF C1-INH, KIT THAT CONSISTS OF ONE SUITABLE DEVICE FOR SUBCUTANEOUS APPLICATION, SUCH AS AN INJECTOR IN THE BODY AND USE OF HISTIDINE TO INCREASE THE CIO-INH BIOAVAILABILITY ADMINISTERED SUBCUTANEOUSLY
the present invention relates to a stable c1-esterase (c1-inh) inhibitor preparation, which is liquid or lyophilized, characterized by a histidine content of 5 to 400 mm, but does not contain citrate or phosphate. the present invention further relates to a kit that includes the preparation of c1-inh.a presente invenção refere-se a uma preparação de inibidor de c1-esterase (c1-inh) estável, que é líquida ou liofilizada, caracterizada por um teor de histidina de 5 a 400 mm, mas não contém citrato ou fosfato. a presente invenção ainda se refere a um kit que inclui a preparação de c1-inh.
